North Augusta, South Carolina — According to state and local development sources, AmbioPharm plans to invest $118,960,000.00 to expand in North Augusta. The company is creating 202 new jobs at this facility. The company plans to occupy the new space in North Augusta, on or about December 1, 2027. According to the company website AmbioPharm is a global custom synthetic peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at clinical and commercial stages. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA as well as other global regulatory bodies with excellent outcomes. Our mission is to accelerate your peptides to patients.

To learn more, visit https://www.ambiopharm.com/

Company Contact:
AmbioPharm
1024 Dittman Ct
Clearwater, SC29842
Phone: 803-442-7590
LinkedIn Link: https://www.linkedin.com/company/ambiopharm/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.